A multidimensional analysis of genes mutated in breast and colorectal cancers

  1. Jimmy Lin,
  2. Christine M. Gan,
  3. Xiaosong Zhang,
  4. Siân Jones,
  5. Tobias Sjöblom,
  6. Laura D. Wood,
  7. D. Williams Parsons,
  8. Nickolas Papadopoulos,
  9. Kenneth W. Kinzler,
  10. Bert Vogelstein,
  11. Giovanni Parmigiani, and
  12. Victor E. Velculescu1
  1. Ludwig Center for Cancer Genetics and Therapeutics, and The Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland 21231, USA

Abstract

A recent study of a large number of genes in a panel of breast and colorectal cancers identified somatic mutations in 1149 genes. To identify potential biological processes affected by these genes, we examined their putative roles based on sequence similarity, membership in known functional groups and pathways, and predicted interactions with other proteins. These analyses identified functional groups and pathways that were enriched for mutated genes in both tumor types. Additionally, the results pointed to differences in molecular mechanisms that underlie breast and colorectal cancers, including various intracellular signaling and metabolic pathways. These studies provide a multidimensional framework to guide further research and help identify cellular processes critical for malignant progression and therapeutic intervention.

Footnotes

  • 1 Corresponding author.

    1 E-mail velculescu{at}jhmi.edu; fax (410) 955-0548.

  • [Supplemental material is available online at www.genome.org.]

  • Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.6431107

    • Received February 23, 2007.
    • Accepted June 28, 2007.
| Table of Contents

Preprint Server